Your browser doesn't support javascript.
loading
Low-dose Pimecrolimus, an FDA-approved Calcineurin Inhibitor, Sensitizes Drug-resistant Cancer Cells via Strong P-gp Inhibition.
Park, Jae Hyeon; Lee, Ji Sun; Shin, Joo Kyung; Sharma, Swati; Kim, Hyung Sik; Yoon, Sungpil.
Affiliation
  • Park JH; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • Lee JS; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • Shin JK; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • Sharma S; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • Kim HS; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • Yoon S; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea syoon88@gmail.com.
Anticancer Res ; 43(3): 1103-1112, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36854528
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tacrolimus / ATP Binding Cassette Transporter, Subfamily B, Member 1 / Calcineurin Inhibitors / Neoplasms Limits: Humans Language: En Journal: Anticancer Res Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tacrolimus / ATP Binding Cassette Transporter, Subfamily B, Member 1 / Calcineurin Inhibitors / Neoplasms Limits: Humans Language: En Journal: Anticancer Res Year: 2023 Document type: Article Country of publication: